Virus-induced dilated cardiomyopathy is characterized by increased levels of fibrotic extracellular matrix proteins and reduced amounts of energy-producing enzymes

Proteomics

Volumn 11, Issue 22, 2011, Pages 4310-4320

  Nishtala, Krishnatej ^a   Phong, Truong Q ^a   Steil, Leif ^a   Sauter, Martina ^b   Salazar, Manuela G ^a   Kandolf, Reinhard ^b   Kroemer, Heyo K ^c   Felix, Stephan B ^c   Völker, Uwe ^a   Klingel, Karin ^b   Hammer, Elke ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c UNIVERSITY MEDICINE GREIFSWALD   (Germany)

Author keywords

Coxsackievirus B3 induced dilated cardiomyopathy; Differential in gel electrophoresis; LC MS based quantitation; Murine model

Indexed keywords

ENZYME; MATRIX PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; COXSACKIE VIRUS B3; COXSACKIE VIRUS INFECTION; ENERGY METABOLISM; EXTRACELLULAR MATRIX; FATTY ACID METABOLISM; FLUORESCENCE; HISTOPATHOLOGY; IMMUNITY; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOUSE; MUSCLE CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN MODIFICATION; PROTEOMICS; RESPIRATORY CHAIN; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; VIRUS MYOCARDITIS;

ANIMALS; BLOTTING, WESTERN; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; COXSACKIEVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENERGY METABOLISM; ENTEROVIRUS B, HUMAN; ENZYMES; EXTRACELLULAR MATRIX PROTEINS; IMMUNOHISTOCHEMISTRY; MASS SPECTROMETRY; METABOLIC NETWORKS AND PATHWAYS; MICE; PROTEOME; REPRODUCIBILITY OF RESULTS; VENTRICULAR REMODELING;

COXSACKIEVIRUS; MURINAE; MUS;

EID: 80055118797     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201100229     Document Type: Article

References (46)

1. Martino, T. A., Liu, P., Sole, M. J., Viral infection and the pathogenesis of dilated cardiomyopathy. Circ. Res. 1994, 74, 182-188.
2. Kuhl, U., Pauschinger, M., Seeberg, B., Lassner, D. et al., Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 2005, 112, 1965-1970.
3. Kawai, C., From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation 1999, 99, 1091-1100.
4. Badorff, C., Lee, G. H., Lamphear, B. J., Martone, M. E. et al., Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat. Med. 1999, 5, 320-326.
5. Klingel, K., Hohenadl, C., Canu, A., Albrecht, M. et al., Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc. Natl. Acad. Sci. USA 1992, 89, 314-318.
6. Fu, Q., Van Eyk, J. E., Proteomics and heart disease: identifying biomarkers of clinical utility. Exp. Rev. Proteomics 2006, 3, 237-249.
7. Magnusson, Y., Wallukat, G., Waagstein, F., Hjalmarson, A., Hoebeke, J., Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect. Circulation 1994, 89, 2760-2767.
8. Takata, S., Nakamura, H., Umemoto, S., Yamaguchil, K. et al., Identification of autoantibodies with the corresponding antigen for repetitive coxsackievirus infection-induced cardiomyopathy. Circ. J. 2004, 68, 677-682.
9. Esfandiarei, M., McManus, B. M., Molecular biology and pathogenesis of viral myocarditis. Ann. Rev. Pathol. 2008, 3, 127-155.
10. Rutschow, S., Leschka, S., Westermann, D., Puhl, K. et al., Left ventricular enlargement in coxsackievirus-B3 induced chronic myocarditis - ongoing inflammation and an imbalance of the matrix degrading system. Eur. J. Pharmacol. 2010, 630, 145-151.
11. Kandolf, R., Selinka, H., Klingel, K., in: Semler, B., Wimmer, E. (Eds.), Pathogenesis of Coxsackievirus B Infections. Molecular Biology of Picornaviruses, American Society of Microbiology, Washingtion, DC 2002, pp. 405-413.
12. Baboonian, C., Treasure, T., Meta-analysis of the association of enteroviruses with human heart disease. Heart 1997, 78, 539-543.
13. Yang, D., Yu, J., Luo, Z., Carthy, C. M. et al., Viral myocarditis: identification of five differentially expressed genes in coxsackievirus B3-infected mouse heart. Circ. Res. 1999, 84, 704-712.
14. Taylor, L. A., Carthy, C. M., Yang, D., Saad, K. et al., Host gene regulation during coxsackievirus B3 infection in mice: assessment by microarrays. Circ. Res. 2000, 87, 328-334.
15. Hammer, E., Phong, T. Q., Steil, L., Klingel, K. et al., Viral myocarditis induced by Coxsackievirus B3 in A.BY/SnJ mice: analysis of changes in the myocardial proteome. Proteomics 2010, 10, 1802-1818.
16. Thompson, S. R., Sarnow, P., Regulation of host cell translation by viruses and effects on cell function. Curr. Opin. Microbiol. 2000, 3, 366-370.
17. Rassmann, A., Henke, A., Zobawa, M., Carlsohn, M. et al., Proteome alterations in human host cells infected with coxsackievirus B3. J. Gen. Virol. 2006, 87, 2631-2638.
18. Thiele, T., Steil, L., Gebhard, S., Scharf, C. et al., Profiling of alterations in platelet proteins during storage of platelet concentrates. Transfusion 2007, 47, 1221-1233.
19. Blum, H., Beier, H., Gross, H. J., Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels. Electrophoresis 1987, 8, 93-99.
20. Martens, L., Hermjakob, H., Jones, P., Adamski, M. et al., PRIDE: the proteomics identifications database. Proteomics 2005, 13, 3537-3545.
21. Barsnes, H., Vizcaíno, J. A., Eidhammer, I., Martens, L., PRIDE converter: making proteomics data-sharing easy. Nat. Biotechnol. 2009, 27, 598-599.
22. Old, W. M., Meyer-Arendt, K., Aveline-Wolf, L., Pierce, K. G. et al., Comparison of label-free methods for quantifying human proteins by shotgun proteomics. Mol. Cell. Proteomics 2005, 4, 1487-1502.
23. Cima, I., Schiess, R., Wild, P., Kaelin, M. et al., Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer. Proc. Natl. Acad. Sci. USA 2011, 108, 3342-3347.
24. Jungblut, P. R., Holzhutter, H. G., Apweiler, R., Schluter, H., The speciation of the proteome. Chem. Cent. J. 2008, 2, 16.
25. Kim, S. C., Sprung, R., Chen, Y., Xu, Y. et al., Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol. Cell 2006, 23, 607-618.
26. Szalay, G., Meiners, S., Voigt, A., Lauber, J. et al., Ongoing coxsackievirus myocarditis is associated with increased formation and activity of myocardial immunoproteasomes. Am. J. Pathol. 2006, 168, 1542-1552.
27. Taylor, L. A., Carthy, C. M., Yang, D., Saad, K. et al., Host gene regulation during coxsackievirus B3 infection in mice: assessment by microarrays. Circ. Res. 2000, 87, 328-334.
28. Szalay, G., Sauter, M., Haberland, M., Zuegel, U. et al., Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host. Circ. Res. 2009, 104, 851-859.
29. Dai, Q., Escobar, G. P., Hakala, K. W., Lambert, J. M. et al., The left ventricle proteome differentiates middle-aged and old left ventricles in mice. J. Proteome Res. 2008, 7, 756-765.
30. Trahair, T., Yeoh, T., Cartmill, T., Keogh, A. et al., Myosin light chain gene expression associated with disease states of the human heart. J. Mol. Cell. Cardiol. 1993, 25, 577-585.
31. Perry, S. V., Troponin I: inhibitor or facilitator. Mol. Cell. Biochem. 1999, 190, 9-32.
32. Robinson, P., Mirza, M., Knott, A., Abdulrazzak, H. et al., Alterations in thin filament regulation induced by a human cardiac troponin T mutant that causes dilated cardiomyopathy are distinct from those induced by troponin T mutants that cause hypertrophic cardiomyopathy. J. Biol. Chem. 2002, 277, 40710-40716.
33. Winegrad, S., Myosin binding protein C, a potential regulator of cardiac contractility. Circ. Res. 2000, 86, 6-7.
34. Knecht, M., Regitz-Zagrosek, V., Pleissner, K. P., Jungblut, P. et al., Characterization of myocardial protein composition in dilated cardiomyopathy by two-dimensional gel electrophoresis. Eur. Heart J. 1994, 15, 37-44.
35. Kania, G., Blyszczuk, P., Eriksson, U., Mechanisms of cardiac fibrosis in inflammatory heart disease. Trends Cardiovasc. Med. 2009, 19, 247-252.
36. Polyakova, V., Loeffler, I., Hein, S., Miyagawa, S. et al., Fibrosis in endstage human heart failure: severe changes in collagen metabolism and MMP/TIMP profiles. Int. J. Cardiol. 2011, 151, 18-33.
37. Weber, K. T., Cardiac interstitium in health and disease: the fibrillar collagen network. J. Amer. Coll. Cardiol. 1989, 13, 1637-1652.
38. Naugle, J. E., Olson, E. R., Zhang, X., Mase, S. E. et al., Type VI collagen induces cardiac myofibroblast differentiation: implications for postinfarction remodeling. Am. J. Physiol. Heart Circ. Physiol. 2006, 290, H323-H330.
39. Bianco, P., Fisher, L. W., Young, M. F., Termine, J. D., Robey, P. G., Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. J. Histochem. Cytochem. 1990, 38, 1549-1563.
40. Baba, H., Ishiwata, T., Takashi, E., Xu, G., Asano, G., Expression and localization of lumican in the ischemic and reperfused rat heart. Jpn. Circ. J. 2001, 65, 445-450.
41. Onda, M., Ishiwata, T., Kawahara, K., Wang, R. et al., Expression of lumican in thickened intima and smooth muscle cells in human coronary atherosclerosis. Exp. Mol. Pathol. 2002, 72, 142-149.
42. Lopaschuk, G. D., Ussher, J. R., Folmes, C. D., Jaswal, J. S., Stanley, W. C., Myocardial fatty acid metabolism in health and disease. Physiol. Rev. 2010, 90, 207-258.
43. Stanley, W. C., Recchia, F. A., Lopaschuk, G. D., Myocardial substrate metabolism in the normal and failing heart. Physiol. Rev. 2005, 85, 1093-1129.
44. Buchwald, A., Till, H., Unterberg, C., Oberschmidt, R. et al., Alterations of the mitochondrial respiratory chain in human dilated cardiomyopathy. Eur. Heart J. 1990, 11, 509-516.
45. Jarreta, D., Orús, J., Barrientos, A., Miró, O. et al., Mitochondrial function in heart muscle from patients with idiopathic dilated cardiomyopathy. Cardiovasc. Res. 2000, 45, 860-865.
46. Hammer, E., Bien, S., Salazar, M. G., Steil, L. et al., Proteomic analysis of doxorubicin-induced changes in the proteome of HepG2cells combining 2-D DIGE and LC-MS/MS approaches. Proteomics 2010, 10, 99-114.